Search Browse Earnings

Surrozen, Inc./DE

Nasdaq:SRZNNasdaq:SRZNW

Biological Products, (No Diagnostic Substances)·SOUTH SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2024

Adj. EBITDA

-$43.9M

FY 2024

Net Income

-$43.0M

FY 2024

EPS (Diluted)

-$21.33

FY 2024

Stock Price

$25.90

-3.9%

2026-03-12

52W Range

$5.90 – $29.59

P/E Ratio

-1.2x

Market Cap

$222.0M

Cash

$36.0M

FY 2024

Total Debt

—

Net Cash

$36.0M

FY 2024

Enterprise Value

$186.0M

Debt / EBITDA

0.8x

FY 2024

EV / EBITDA

-4.2x

Employees

59

FY 2024